Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata

Main Article Content

Justin Ko
Amy McMichael
Antonella Tosti
Taisuke Ito
Yves Dutronc
Guanglei Yu
Yunfei Chen
Mwangi Murage
Chiara Chiasserini
Arash Mostaghimi


Baricitinib, Alopecia Areata


1. Mesinkovska N, et al. J Investig Dermatol Symp Proc. 2020;20:S62-S68.

2. King B, et al. J Am Acad Dermatol. 2021;85:847-853.

3. King B, et al. N Engl J Med. 2022;386:1687-1699.

4. Wyrwich KW, et al. Am J Clin Dermatol. 2020;21:725-732.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>